You are here

  • Home
  • Archive
  • Volume 72, Issue 10
  • A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study

Article metrics

Article menu
Clinical and epidemiological research
Extended report
A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study

 

Online download statistics by month:

Online download statistics by month: May 2013 to March 2024

AbstractFullPdf
May 2013961323350
Jun 2013478304397
Jul 2013348264212
Aug 2013367133132
Sep 20132645351490
Oct 20132532259246
Nov 20131002167230
Dec 201331499135
Jan 2014266170208
Feb 2014280154198
Mar 2014261162123
Apr 2014183143131
May 2014182155144
Jun 2014159142191
Jul 2014167148125
Aug 201418820188
Sep 2014182131126
Oct 2014194172129
Nov 2014156117155
Dec 2014194165139
Jan 2015240147165
Feb 2015207347298
Mar 2015248213165
Apr 2015189228127
May 2015168127141
Jun 2015162110138
Jul 201513311295
Aug 2015161166100
Sep 2015187243106
Oct 201510411876
Nov 2015163100117
Dec 2015171120128
Jan 2016159116123
Feb 201616110083
Mar 2016178111114
Apr 2016194121121
May 2016279165143
Jun 2016163114151
Jul 201613195136
Aug 2016136120132
Sep 2016161137114
Oct 2016146170156
Nov 2016175194129
Dec 201617410999
Jan 2017143118112
Feb 201795139111
Mar 20174217295
Apr 201765221101
May 20175219693
Jun 20178014677
Jul 201721115081
Aug 201726116399
Sep 201725515770
Oct 201724015082
Nov 201725415752
Dec 201720311759
Jan 201815710746
Feb 201818810847
Mar 201821010151
Apr 201821711782
May 201826517361
Jun 201818611355
Jul 201816510945
Aug 20181618868
Sep 20181379561
Oct 201822411386
Nov 201814410071
Dec 20181409699
Jan 201915813175
Feb 20191148965
Mar 20191349174
Apr 20191449187
May 20191349064
Jun 20191238373
Jul 2019153120102
Aug 20191337481
Sep 2019966863
Oct 20191027347
Nov 20191136761
Dec 201920717045
Jan 20201348955
Feb 202016111653
Mar 202012710937
Apr 20201128266
May 202013712146
Jun 20201119140
Jul 2020937325
Aug 20201028834
Sep 202017312869
Oct 2020967742
Nov 2020978045
Dec 202015911732
Jan 20211128660
Feb 202113310671
Mar 202113610255
Apr 20211076858
May 20211139053
Jun 2021908938
Jul 2021979646
Aug 2021939361
Sep 202111311244
Oct 202116414261
Nov 20211138956
Dec 202122217680
Jan 202214411956
Feb 202217313342
Mar 202218815866
Apr 20221218444
May 202215412546
Jun 202216713141
Jul 20221299326
Aug 202214512134
Sep 202212110336
Oct 202211210746
Nov 20221179236
Dec 20221277926
Jan 202315812640
Feb 202314312226
Mar 20231046729
Apr 20231057048
May 20231066836
Jun 20231048237
Jul 2023795642
Aug 202313911247
Sep 202313610542
Oct 202328223434
Nov 202329024333
Dec 202336822563
Jan 20249289149
Feb 20241579328
Mar 202415411528
Total280651726812155